Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes

Diabetes/Metabolism Reviews

Volumn 5, Issue 8, 1989, Pages 665-689

  Caro, José F ^a   Dohm, Lynis G ^a   Pories, Walter J ^a   Sinha, Madhur K ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR;

ADIPOSE TISSUE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; SKELETAL MUSCLE;

ADIPOSE TISSUE; CELLS, CULTURED; DIABETES MELLITUS, INSULIN-DEPENDENT; GLUCOSE; HUMAN; INSULIN; INSULIN RESISTANCE; LIVER; MUSCLES; OBESITY IN DIABETES; RECEPTOR, INSULIN; SECOND MESSENGER SYSTEMS;

EID: 0024936235     PISSN: 07424221     EISSN: 10990895     Source Type: Journal    
DOI: 10.1002/dmr.5610050804     Document Type: Article

References (92)

1. Diabetes mellitus: A differentiation into insulin‐sensitive and insulin‐insensitive types
2. Classification and progress of diabetes mellitus and other categories of glucose intolerance
3. Obesity: Basic aspects and clinical applications
4. Lilly Lecture 1987. The triumvirate: β cell, muscle, liver. A collusion responsible for NIDDM
5. Banting Lecture 1988. Role of insulin resistance in humans
6. Cellular mechanisms of insulin resistance in non‐insulin‐dependent (type II) diabetes
7. Mechanism of impaired insulin action in isolated adipocytes from obese and diabetic subjects
8. Role of insulin resistance in the pathogenesis of type II (non‐insulin‐dependent) diabetes mellitus
9. Pathogenesis of NIDDM—A disease of deficient insulin secretion
10. Insulin secretion in diabetes mellitus
11. Mechanism and significance of insulin resistance in non‐insulin‐dependent diabetes mellitus
12. Cellular alterations responsible for insulin resistance in obesity and type II diabetes mellitus
13. The minimal modeling method
14. Glucose clamp technique: A method for quantifying insulin action and resistance
15. An in vitro human muscle preparation suitable for metabolic studies. Decreased glucose transport in muscle from morbidly obese subjects
16. Long‐term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non‐insulin dependent diabetes
17. The insulin receptor and the molecular mechanism of insulin action
18. Banting Lecture 1987. Insulin‐signaling mechanism(s): Lessons from the old testament of glycogen metabolism and the new testament of molecular biology
19. The insulin receptor: Molecular biology and transmembrane signaling
20. Molecular and cellular biology of the insulin receptor in diabetes mellitus
21. In search of a second messenger for insulin
22. After insulin binds
23. Glycerolipid mediators of insulin action
24. Calcium and insulin action
25. Mechanism of signaling by insulin receptor kinase
26. Hormonal regulation of mammalian glucose transport
27. Insulin stimulates the phosphorylation of the 95,000 dalton subunit of its own receptor
28. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
29. The human insulin receptor cDNA: The structural basis for hormone‐activated transmembrane signalling
30. Replacement of lysine residue 1030 in the putative ATP‐binding region of the insulin receptor abolishes insulin‐ and antibody‐stimulated glucose uptake and receptor kinase activity
31. Human insulin receptors mutated at the ATP‐binding site lack protein tyrosine kinase activity and fail to mediate postre‐ceptor effects of insulin
32. Acute insulin action requires insulin receptor kinase activity: Introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin
33. The effect of antiphosphotyrosine antibodies on insulin receptor phosphorylation and insulin response in rat hepatoma cells
34. Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity
35. An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity
36. Heterogeneity of human liver, muscle and adipose tissue insulin receptor
37. Inhibitor of protein kinase formed in insulin treated muscle
38. Intracellular mediators of insulin action
39. Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid
40. Identification of a novel insulin‐sensitive glycophospholipid from H35 hepatoma cells
41. Phospho‐dephospho‐control by insulin is mimicked by a phospho‐oligosaccharide in adipocytes
42. Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphatase contains galactosamine and D‐chiroinositol
43. An autocrine factor from Reuber hepatoma cells that stimulates DNA synthesis and acetil‐CoA carboxylase
44. Insulin‐induced glycerolipid mediators and the stimulation of glucose transport in BC 3H‐1 myocytes
45. Purification of a phosphatidylinositolglycan‐specific phospholipase C from liver plasma membrane: A possible target of insulin action
46. Inositol trisphosphate, a novel second messengers
47. Evidence that the insulin receptor‐associated protein kinase acts as a phosphatidylinositol kinase
48. 2+‐calmodulin stimulate the formation of polyphosphoinositides in a sarcoplasmic reticulum preparation of rabbit heart
49. Insulin, glucagon and the receptormediated control of cyclic AMP concentrations in liver. Twenty‐second Colworth medal lecture
50. Action of insulin modulated by pertussis toxin in rat adipocytes
51. Insulin inhibits pertussis‐toxin catalyzed ribosylation of G‐proteins
52. Insulin regulatable tissues express a unique insulin‐sensitive glucose transport protein
53. Sequence, tissue distribution, and differential expression of mRNA for a putative insulin‐responsive glucose transporter in mouse 3T3–11 adipocytes
54. Molecular cloning and characterization of an insulin‐regulatable glucose transporter
55. Sequence and structure of a human glucose transporter
56. Studies on the mechanism of insulin resistance in the liver from humans with non‐insulin‐dependent diabetes: Insulin action and binding in isolated hepatocytes, insulin receptor structure and kinase activity
57. Insulin stimulated protein phosphorylation in human plasma liver membranes: Detection of endogenous or plasma membrane associated substrates for insulin receptor kinase
58. Insulin receptor kinase activity of adipose tissue from morbidly obese humans with or without noninsulin‐dependent diabetes
59. Decreased kinase activity of insulin receptors from adipocytes of non‐insulin‐dependent diabetic subjects
60. Alterations in insulin receptor autophosphorylation in insulin resistance: Correlation with altered sensitivity to glucose transport and antilipolysis to insulin
61. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes
62. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non‐insulin‐dependent) diabetes mellitus
63. Relationship of insulin binding and insulin‐stimulated tyrosine kinase activity is altered in type II diabetes
64. A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non‐insulin‐dependent diabetes mellitus
65. Effect of insulin and insulin‐like growth factors I and II on phosphatidylinositol and phosphatidyl‐inositol‐4,5‐biphosphate breakdown in liver plasma membranes from humans with and without type II diabetes
66. Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin C
67. Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia
68. Metabolic studies in unaffected cotwins of non‐insulin‐dependent diabetics
69. Diabetes in identical twins
70. Concordance for Type 2 (non‐insulin‐dependent) diabetes mellitus in male twins
71. Genes and diabetes mellitus
72. Studies of liver insulin receptors in non‐obese and obese human subjects
73. Characterization of insulin‐like growth factor I receptor in skeletal muscles of normal and insulin resistant subjects
74. Reversibility of defective adipocyte insulin receptor kinase activity in non‐insulin‐dependent diabetes mellitus
75. Guanine‐nucleotide and hormone regulation of polyphosphoinositide phospholipase C activity of rat liver plasma membranes
76. 2+ on the metabolism of phosphatidylinositol 4‐phosphate and phosphatidylinositol 4,5‐biphosphate in isolated rat hepatocytes and plasma membranes
77. Insulin and oxytocin effects on phosphoinositide metabolism in adipocytes
78. Role of glucose transporters in the cellular insulin resistance of type II diabetes mellitus
79. Effect of monoclonal insulin receptor antibodies on glucose transport in adipocytes from NIDDM patients
80. IGF‐I stimulated glucose transport, IGF‐I receptors and tyrosine kinase are not altered as noted for insulin in adipocytes from NIDDM patients
81. IGF‐I and IGF‐II stimulated glucose transport in human skeletal muscle
82. Decreased expression of the insulin‐responsive glucose transporter in diabetes and fasting
83. Pretranslational suppression of an insulin‐responsive glucose transporter in rats with diabetes mellitus
84. Regulation of glucose transporter messenger RNA in insulin‐deficient states
85. Glucose uptake in human adipose tissue
86. Increased in vivo glucose utilization in 30‐day‐old obese Zucker rat: Role of white adipose tissue
87. Diabetes mellitus: A thrifty genotype rendered detrimental by “progress.”